LSA
AKBA icon

Leonteq Securities AG’s Akebia Therapeutics AKBA Stock Holding History

Leonteq Securities AG’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,000
Closed -$16.9K – 1060
2021
Q1 		$16.9K Sell
5,000
-15,000
-75% -$54K ﹤0.01% 901
2020
Q4 		$56K Buy
+20,000
New +$58.4K ﹤0.01% 764

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Leonteq Securities AG's AKBA Position: Q2 2021 in Review

Leonteq Securities AG sold out of Akebia Therapeutics (AKBA) in Q2 2021, closing a stake of 5,000 shares — an estimated $16.9K sold.

Leonteq Securities AG first reported a position in AKBA in Q4 2020 and held it in 2 quarters. The position peaked at $56K in Q4 2020. 139 funds tracked by Wall St. Rank hold AKBA as of Q2 2021.

  • Leonteq Securities AG reported no remaining Akebia Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Leonteq Securities AG sold 5,000 Akebia Therapeutics shares in Q2 2021, an estimated $16.9K.
  • Leonteq Securities AG first reported a position in Akebia Therapeutics in Q4 2020 and held it in 2 quarters.
  • Leonteq Securities AG's Akebia Therapeutics position peaked at $56K in Q4 2020.
  • 139 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2021.

Based on Leonteq Securities AG's 13F filing for Q2 2021, filed 26 Mar 2026.